In silico analyses indicated that several of the SNPs associated with U-Hg alter putative transcription-factor binding sites, which indicate that they may influence gene expression.
However, reporter activity modulations occurred following mutations of any binding site which indicates that they are all functional.
This transcription factor binding site search identified multiple putative krüppel-like transcription factor binding sites which are indicated in Figure 5A.
However, contrary to the case of pRA2, we were unable to identify, close to this ORF, or elsewhere in the plasmid, iterons or DnaA binding sites, which may have indicated the presence of an origin of replication.
Our analysis indicated potential ligand binding sites which encompass the junction region of the EWS-FLI1 protein and that the region was likely to have a structure indicated by alpha helical and beta pleated structures.
These results indicate that Atrx deficiency abnormally alters H3.3 composition at vacant Atrx binding sites, which in turn mediates, at least in part, shifts in chromatin accessibility and gene expression driving glioma-relevant phenotypes.
A survey of the promoter regions of c-Met, PDGFα, TGFβ2, MITF, N-CAM, c-RET, MyoD and Tyrp-1 indicates that the FRα binding motif AANTT or NTTTTN and/or NAAAAN map close to Pax3, a transcription factor and multifunctional regulatory protein, expressed early in embryogenesis, binding sites, which map to ATTA, GTTCC, TAAT, CCTTG, CAAGG, GTTAT, TATTG, GTGTGA, and CAGTGT27.
Patients with prostate, ovary, and skin cancer may develop auto-antibodies to the alpha(2)M* binding site which are receptor agonists whose presence indicates a poor prognosis.
Specificity indicates the proportion of the residues predicted to be in the binding site which are actually in the binding site.
Any binding site which had a p < 0.01 was annotated as a potential miRNA binding site.
